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Abstract- Activation of the acto-myosin complex is controlled by the regulatory proteins 
tropomyosin (Tm) and troponin (Tn) which is made up of the C, I and T subunits. TnC 
undergoes a conformational change upon calcium binding triggering the release of actin by TnI 
thereby allowing the TmTn complex to move away from myosin binding sites. This process is 
known as regulation. Regulation allows for what is known as cooperativity, or the ability of a 
single initial event to make a subsequent event more or less likely. As this relates to muscle 
mechanics cooperativity is defined in two ways, these being calcium sensitive and myosin 
dependent respectively. With regard to myosin dependency cooperativity is a measure of the 
ability of one myosin head binding the thin filament to increase the chances of another myosin 
head binding to the thin filament and is therefore related to the number of myosin heads bound to 
the thin filament (𝑁𝑏). Cooperativity is related to calcium sensitivity in that the regulatory 
complex must move away from the actin binding sites for a myosin head to bind. In addition to 
myosin dependent this becomes calcium dependent with the binding of calcium to the TnC 
subunit of Tn. In vitro motility assays were used to study the cooperative nature of thin filament 
activation measuring the velocity of the actin+TmTn complex. Velocities of the thin filament 
were measured while varying myosin density, pCa, and at constant myosin density varying pCa 
with results showing that with increasing myosin concentration there is a decrease in 
cooperativity based on the Hill function cooperative coefficient. In addition this shows an 
increase in 𝑝𝐶𝑎50, or the concentration of calcium at which we attain half maximal velocity of 
the thin filament. With a decrease in myosin density there is an increase in cooperativity and a 
subsequent decrease in 𝑝𝐶𝑎50 . This 𝑝𝐶𝑎50 value is known to be affected by the duty ratio, 
whereas cooperativity is again a function of Nb. In addition the effects of phosphate on the 




varying the concentration of myosin density and the presence of phosphate.  Experiments were 
performed using rabbit striated muscle. Additional studies of the binding pathways of actin-
myosin interactions were done using N,N’p-phenylenedimaleimide (pPDM) which is a structural 
analogue of myosin subfragment-1 thought to force actin-myosin interaction towards a weakly 
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Actin-Myosin Kinetics and the Effect of Myosin Binding on Cooperative Thin Filament 
Activation 
Introduction- The thin filament of striated muscle is activated by both calcium binding to a 
regulatory protein complex, and myosin heads binding to the thin filament which leads to the 
contraction of muscle as the thin and thick filaments slide past each other. The regulatory 
proteins that control this process are known as troponin (Tn) and tropomyosin (Tm). Tn is 
composed of three subunits, C, I, and T and upon calcium binding of the C subunit the TnI 
subunit changes conformation to an open E-F hands conformation of the TnC subunit. This 
allows for the movement of the TmTn complex off of the myosin binding sites on the thin 
filament. This brings about a partially blocked calcium induced state that allows for activation of 
the thin filament upon myosin binding. Such binding further displaces Tm from the binding sites 
along the thin filament. We have thus established the premise for both calcium and myosin 
dependent activation of the thin filament and through regulation, have established a mechanism 
through which cooperativity could affect activation of the thin filament. For the purposes of this 
paper we will define cooperativity as the ability of a single event to make a subsequent event 
more or less likely.  
 Common models, such as those proposed by Geeves, discuss activation through a 
structural perspective in which there exist distinct states of activation that are in effect, separated 
from each other without regard for the physiological transition between such states. In contrast 
we will explore a more simple model of thin filament regulation (SCoR) that includes the 
assumption that kinetics and structural dynamics work hand in hand when transitioning from a 
deactivated to activated state. We will explore this transition as an integrated process of kinetics 
and structure described by the rate constant katt. This being a chemical representation of thin 




variations in structure are accounted for in the dependence of katt upon calcium and myosin. This 
is based in part on the assumption that calcium dependence of katt follows a Hill function. A 
further assumption stipulates that myosin activation of katt is maximally activated when Nb is 
greater than or equal to 1. However, because of the cooperative nature of myosin activation we 
develop a simple concerted model of regulation (SCoR) in which katt increases with an increase 
in Nb.  
 We show that SCoR accurately predicts a novel relationship between katt, kdet, N and 
𝑝𝐶𝑎50. This is based in SCoR’s ability to predict a linear variation in 𝑝𝐶𝑎50 with N(r) where N is 




).  This is tested through the use of an in vitro motility assay in 
which the speed, V, of the thin filament as it moves over a bed of myosin is measured and used 
as an indicator of the level of activation of the thin filament. Various inhibitors of katt and kdet are 
used and the concentration of calcium is varied to determine their respective affects on 
activation. Results show that a change in any of these parameters results in a corresponding 
change in 𝑝𝐶𝑎50 that is proportional to the change in N(r). In addition any change that returns 
N(r) to its original value will restore 𝑝𝐶𝑎50 to its corresponding value.  
We will also discuss the effect of phosphate on the transition from unbound to strongly bound 
states. There has been detected in muscle fibers a weakly bound state (15). Thus there would 
seem to be two possible pathways to achieve a myosin-actin strongly bound state. These being, a 
transition from dissociated to strongly bound through an intermediate weakly bound state, or a 
single transition from dissociated to strongly bound (figure 15). Weakly bound states could 




states.  However there is some debate about whether or not this weakly bound state actually lies 
on the path from unbound to strongly bound actomyosin interactions (15). With addition of 
phosphate, sliding velocity/ATPase cycle actually slows when compared to a control curve 
varying only myosin density. This suggests two things, one being that there is a saturation of 
productive myosin heads at high concentrations of myosin, and two, that multiple weakly bound 
transition states can become saturated with addition of phosphate and high myosin 
concentrations thus slowing velocity. In addition this might provide insight into whether or not 
the weakly bound state is actually on the pathway to strong binding or merely a momentary 
association between actin and myosin. Evidence for this can be found through an in vitro motility 
assay that shows a departure from maximally activated thin filaments with addition of phosphate 
to varying myosin density. 
In addition a brief study of the effects of N,N’p-phenylenedimaleimide (pPDM) modified myosin 
S-1, which is thought to push actin and myosin towards a weakly bound state (14), was done to 
discern effects of ionic drag on activation.  
The goal of this thesis is to provide insight, including novel predictions, into the role that calcium 
sesnsitivity, myosin dependent activation and cooperativity, and attachment/detachment kinetics 
have in the role of cardiac and skeletal muscle contraction. In short our research shows that, 
through modulation of duty ratio and tuning of calcium sensitivity cardiac and skeletal muscle 
contraction could potentially be restored to normal conditions in disease causing states. In 
addition we provide preliminary evidence that a structural weak binding transition state may 
become saturated with addition of phosphate thus slowing sliding velocity at higher (load 
inducing) myosin concentrations. In addition there is preliminary evidence that a weak binding 




roles of calcium/myosin activation and cooperativity can be applied to further studies of thin 
filament regulation. Direct modulation of these effects by changing duty ratio or myosin 
concentration could lead to effective therapeutic treatment of specific cardiomyopathies or loss 
of function mutations in cardiac and skeletal muscle.  
Methods-  
Buffers 
 The myosin buffer was made using 300mM KCL, 25mM imidazole, 1mM EGTA, 4 mM 
MgCl2, and 10 mM DTT. Actin buffer was made using 50 mM KCl, 50 mM imidazole, 2 mM 
EGTA, 8 mM MgCl2, and 10 mM DTT. For in vitro motility experiments the motility buffer was 
used at 1 mM ATP. Motility buffer contained 25 nM TmTn, 50 mM KCl, 50 mM imidazole, 2 
mM EGTA, 8 mM MgCl2, 10 mM DTT, 0.5% methylcellulose. Stock solutions of sucrose were 
made by dissolving >99.5% pure sucrose, (Sigma-Aldrich, St. Louis, MO) to a concentration of 
80% in distilled water. Amrinone (Sigma-Aldrich, St. Louis, MO) was prepared in 0.5 M lactic 
acid at a concentration of 214 mM, as previously described (1). Buffers were used at a pH of 7.4 
achieved through the use of NaOH. Buffers had oxygen scavenger added to them immediately 
before imaging (~6 mg/ml glucose, 0.03 mg/ml glucose oxidase, 0.05 mg/ml catalase) to 
minimize the effect it would have on the pH of the motility buffers.  
 
Proteins 
Skeletal muscle myosin was prepared from a rabbit psoas muscle as previously described 




ice at 4℃ (6).  In vitro motility assays used 1 μM actin that was incubated with 1 μM 
tetramethyl-rhodamine isothiocyanate (TRITC) phalloidin overnight at 4℃.  Troponin and 
tropomyosin (TmTn) were purified from rabbit skeletal muscle as previously described (2, 3).  1 
μM actin was incubated with 100 nM TmTn for 10-15 minutes prior to use. 
In vitro motility assays 
 
Velocities of fluorescently labeled actin thin filaments were measured as they slid over a 
bed of myosin heads in an in vitro motility assay at 30℃. Flow cells were made by attaching a 
nitrocellulose coated coverslip to a microscope slide with double sided ¼ inch, 5 mils thick 
tape (3M, St. Paul, MN). Myosin, at a concentration of 100 µg/ml was applied to the flow cell 
and was followed by the application of 5 mg/ml BSA and 10 nM TRITC-actin. Each of these 
reagents was incubated for a period of 2 minutes before addition of the next. Finally flow cells 
were washed with an actin buffer prior to addition of the motility buffer. Motility assays were 
performed using a Nikon TE2000 epifluorescence microscope with fluorescence images digitally 
acquired with a Roper Cascade 512B camera (Princeton Instruments, Trenton, NJ).  Each flow 
cell provided three separate 30 second image recordings from three different fields containing 
roughly 20-40 actin filaments. Data from these three separate fields constituted a one (n=1) 
experiment.  
Image Tracking 
 For each sequence of images objects were segmented from the background using binary 
threshold and their positions calculated using SimplePCI software for Image Acquisition and 




centroid algorithm. Trajectories of intersecting filaments were excluded and a minimum distance 
of 5 μm was required to filter smoothly moving filaments.  
SCoR Predictions 
 A simple concerted model of regulation or SCoR was used to predict relationships 
between changes in duty ratio and a subsequent shift in pCa. The simulation was based on a two 
state model and transition probabilities for actin-myosin attachment and detachment were 
determined from parameters for attachment N∙katt' (Eq. 1) and detachment, kdet, kinetic rates, 
where N is the number of available myosin heads for binding an actin thin filament. Fractional 
activation of the thin filament was determined at each step and averaged over the simulation to 
get an average velocity for that simulation as described in equations 1-3. Each simulated velocity 
was obtained from an average of ten 50 second simulations. Simulated calcium dependence of 
velocities was analyzed using a Levenberg=Marquardt minimization algorithm for the Hill 
function given as 𝑉 = 𝑉𝑚𝑖𝑛 + (
𝑉𝑚𝑎𝑥−𝑉𝑚𝑖𝑛
1+10(𝐿𝑜𝑔(𝑝𝐶𝑎0−𝑝𝐶𝑎))𝑛𝐻
). The rate of thin filament-myosin binding 
(katt') is defined as a fraction of the maximal rate of attachment (katt) by equation 1:  
𝑘𝑎𝑡𝑡
′ = 𝑘𝑎𝑡𝑡 [((𝑓𝑐)
[𝐶𝑎2+]𝑛




)] + 𝑘𝑏𝑎𝑠𝑎𝑙 
The calcium dependence of katt is calculated as a Hill function, where n is the cooperativity 
coefficient and Kca is Tn-calcium affinity. The Nb-dependence of katt is based on a hyperbolic 
function where Kma is the number of bound myosin heads to the thin filament necessary to 
achieve half maximal myosin activation of the thin filament. The extent to which calcium- and 
myosin-dependent activation, fc and fm respectively, can be influenced by calcium- or myosin-




a maximum value of katt. This then allows for the fractional activation Af  to be defined as 
equation 2:  
𝐴𝑓 =  
𝑘𝑎𝑡𝑡′
𝑘𝑎𝑡𝑡
≤ 1   
Simulated sliding velocities are calculated from equation 3: 
𝑉 = 𝑑 ∙ 𝑘𝑑𝑒𝑡 ∙ 𝐴𝑓 
The assumption is made that the maximal thin filament sliding velocities Vmax are the product of 
the average myosin step size (d) and the rate of thin filament-myosin detachment (kdet). A 
partially activated filament’s velocity (V) is calculated as the product of Vmax  and Af.  
Results- 
Results show the ability of high density myosin to activate the thin filament at subactivating 
concentrations of calcium (figure 14). Having established the ability of myosin to activate the 
thin filament at subactivating concentrations of calcium varying myosin concentrations in in 
vitro motility assays yields differing slope values when fit with a Hill function. Slopes are 
greatest when the concentration of myosin is the lowest. As concentration of myosin increases 
slope values decrease while Vmax values increase (figure 1). When these slope values are 
plotted as Hill coefficients against concentration of myosin or 𝑁𝑏 we see a decrease in the 
coefficient with increased 𝑁𝑏 (figure 2). Further analysis of the effect of duty ratio on 
cooperativity is shown through the effect of amrinone on the duty ratio (figure 3). Changing the 
amrinone concentration from 2mM to 4mM decreases the slope of the respective pCa curves. 
This is compared to a control and as seen addition of amrinone decreases the slope of the pCa 
curve and thus the calculated Hill coefficients decrease as we increase the concentration of 




kinetics, duty ratio and 𝑁𝑏, we can simulate their effects on cooperativity through the use of the 
SCoR model outlined previously. We thus multiply the concentration of myosin by the duty ratio 
and as the product of this increases we see a decrease in the cooperative coefficient as predicted 
by SCoR (figure 5). 
Amrinone and Sucrose have both been shown to shift the 𝑝𝐶𝑎50 value for in vitro motility curves 
and this is shown in figures 7 and 8 as compared to the control pCa curve (figure 6). The control 
curve gives a 𝑝𝐶𝑎50 value of 6.17 with 𝑝𝐶𝑎50 being the -log concentration of calcium at which 
we see half maximal velocity of the thin filament. For our purposes this half maximal velocity 
corresponds to half maximal activation of the thin filament. A sucrose curve showing compilated 
values from three different curves shows a rightward shift in the 𝑝𝐶𝑎50 that is equal to 5.57 
(figure 7). This is a higher concentration of calcium at half maximal activation than is seen in the 
control curve. It was important to show that not only are velocities decreasing as the 
concentration of calcium is changed but also that the percent of moving filaments decreased as 
well (figure 8). Amrinone shifts the 𝑝𝐶𝑎50 value to the left of the control with a value of 6.42 
(figure 9). This is a lower calcium concentration to achieve half maximal velocity than we see in 
the control curve 𝑝𝐶𝑎50 6.17 (figure 6). This shows a loss of calcium sensitivity. When 
combining the use of sucrose (attachment kinetics) and amrinone (detachment kinetics) (figure 
10)  SCoR predicts a recovery of calcium sensitivity measured in 𝑝𝐶𝑎50 value. With addition of 
4mM amrinone and 120mM sucrose we see a recovery of 𝑝𝐶𝑎50 value to 5.64 and 5.66.  This 
supports our model predictions of altered attachment-detachment kinetics.  
In addition to studies of cooperativity and the effects of manipulated duty ratio and 𝑛𝐻the 
pathway from dissociated to strongly bound actomyosin complexes (figure 15) was studied using 




phosphate curve with 30mM phosphate (figure 11). This study shows that with low 
concentrations of myosin both the control and phosphate curve show highly similar velocities. 
This trend is followed until we reach a myosin concentration of 0.1 mg/ml at which point we 
begin to see a divergence in the velocity of the phosphate curve as the control curve velocity 
continues to increase and maintains a higher velocity than the phosphate curve (figure 11). Data 
points for both the phosphate and control curves were collected at the same concentrations of 
myosin to ensure accurate comparisons. The highest velocity reached in the control curve is 1.85 
while the highest velocity in the phosphate curve is 1.24 at a myosin concentration of 0.05 mg/ml 
and 0.1 mg/ml respectively.  
N,N’p-phenylenedimaleimide (pPDM) is thought to be a structural analogue of myosin S-1 that 
forces actin-myosin binding to occur in a weakly bound transition state. This means that we 
increase the number of ionic interactions between actin and myosin essentially creating a drag 
force that inhibits sliding velocity. This would theoretically shift the 𝑝𝐶𝑎50 in a rightward 
direction towards an increase in calcium concentration to achieve half maximal activation of the 
thin filament. This is shown to be the case in pPDM pCa curves in which the 𝑝𝐶𝑎50 was equal to 





Figure 1. N Dependence of Cooperativity. This figure shows a varying concentration of 
myosin in µg/ml with changing calcium concentration plotted against an average velocity of the 
thin filament in an in vitro motility assay. The assay was done in triplicate for each concentration 





Figure 2. Cooperative Coefficients in Varying Myosin Concentration. This figure shows the 
calculated Hill coefficients for pCa curves of varying myosin density. Concentration of myosin is 
measured in µg/ml and plotted against the Hill Coefficient. Curves were done in triplicate and 
velocities at each pCa value for each concentration of myosin were averaged. Thus slope values 





Figure 3. Duty Ratio Dependent Cooperative Activation. Figure 3 shows a control pCa curve 
and pCa curves with 2mM and 4mM amrinone plotted against the sliding velocity of the thin 
filament over a bed of myosin heads. Curves were done in triplicate and averaged values were fit 





Figure 4. Calculated Hill Coefficients of Amrinone pCa Curves. Hill coefficients were 
calculated from corresponding slope values in figure 3. These were plotted against concentration 
of amrinone in µM. Motility assays were done in triplicate thus slope values were averaged 





Figure 5. Cooperative Coefficient as Predicted by SCoR. This figure shows the predicted 
effect of concentration of myosin multiplied by the duty ratio on the Hill cooperative coefficient 
𝑛𝐻. This is a predicted compilation of the concepts in figures two and four. Each concentration 
of myosin, blue being 10 head, red being 30 heads, and black being 50 heads, has the same 
number of output values and these were calculated using computer simulations of the SCoR 





Figure 6. pCa Control Curve. This figure shows the concentration of calcium plotted against 
the velocity of actin thin filaments. The myosin concentration in this curve is kept at a constant 
with only the concentration of calcium varied. The corresponding table contains the calculated 
values of pCa50 and the slope. These are equal to 6.17 and 20.3 respectively. Concentration of 





Figure 7. Compiled Sucrose Curves. Figure 7 shows the compilation of three different sucrose 
pCa curves in which sucrose was added to the motility tube of an in vitro motility assay and the 
concentration of calcium was varied and plotted against the velocity of the thin filament. The 
pCa50 value corresponds to LOGx0 in the table and is equal to 5.57 while the slope is 1.13 given 





Figure 8. Percent Motile Filaments in Varying Concentration of Calcium. This shows the % 
of moving filaments in a pCa control curve. Filaments were counted during a single frame. The 
number of moving filaments were counted by advancing and retreating the film by 5-10 frames 
on each side of the original frame. Each concentration of calcium required three different 





Figure 9. 4mM Amrinone pCa Curve. Figure 9 shows a varying concentration of calcium 
plotted against velocity. Curves were done in triplicate and averaged into this graph.  The 
motility tube contains 4mM amrinone. 𝑝𝐶𝑎50  value is 6.42 with a slope value of 1. Data was fit 





Figure 10. Sucrose Recovery of Calcium Sensitivity.  A) Shows the predicted effects of 
decreased 𝑘𝑑𝑒𝑡 and decreased 𝑘𝑑𝑒𝑡 and 𝑘𝑎𝑡𝑡 as predicted by SCoR and their effects on actin 
sliding velocities. B) Shows a more complex manipulation of attachment detachment kinetics 
with use of 4mM amrinone and rescue by sucrose to return pCa50 values to 5.64 and 5.66.  This 
is consistent with SCoR showing that altering both attachment (sucrose) and detachment 





Figure 11. Phosphate Effect on Actin-Myosin Binding Pathway. This figure shows the effect 
of phosphate (red squares) on thin filament velocities with varying myosin density against a 
control (black squares). The phosphate curve contains a 30𝑚𝑀 concentration of phosphate which 
was added to the motility tube. Both of these curves are unregulated and thus lack TmTn and 





Figure 12. pPDM Effect on pCa50. Shows the effect of N,N’p-phenylenedimaleimide (pPDM) 
in modified myosin S-1 on pCa50 of a pCa in vitro motility assay. pCa50 is equal to 4.91 with a 
slope of 5.57 as calculated by the Rose/Departure fit. Varying calcium concentration is plotted 
against the velocity of the thin filament. pPDM is thought to be a structural analogue of myosin 






Figure 13. ATPase Cycle of Actomyosin Binding as Affected by Sucrose and Amrinone. 
Amrinone is known to be an ADP release inhibitor which prolongs the strongly bound state 
while sucrose is believed to affect attachment kinetics by inhibiting a weak to strong transition. 
Amrinone and high density myosin are expected to increase the lifetime of a strongly bound state 
while sucrose and low myosin density are expected to increase the lifetime of a weakly bound 
state. Yellow denotes a weakly bound state or transition, red denotes a strongly bound state or 





Figure 14. Myosin Density Induced Recovery of Activation at Subactivating Calcium. This 
figure shows a varying density of myosin at a constant calcium concentration of pCa6. This is 
plotted against the sliding velocity of an actin thin filament in an in vitro motility assay. pCa6 is 
generally considered to be a subactivating concentration of calcium in in vitro motility. Myosin 





Figure 15. Actin-Myosin Binding Pathways and Equilibriums. This figure shows the various 
equilibriums that actin and myosin with ATP, ADP, and phosphate form during dissociated, 
weakly bound, and strongly bound states. The red pathway shows a progression in which actin 
and myosin transition from dissociated to strongly bound (green circle). The blue pathway 
denotes a weak binding intermediate state between dissociation and strong binding. Phosphate 
release allows transition to a strongly bound state.  
 
Discussion- 
The effects of actin-myosin ATPase kinetics on the regulation of the thin filament and the 
pathway by which this cycle operates are not well understood. The goal of this thesis is to 
improve the description of these kinetic properties and the effects they have on cooperativity in 
muscle contraction as well as define which parts of this cycle can be affected by various 
inhibitors. In addition an insight into the weakly bound transition state is provided through the 




which these parameters can be changed and predicted accurately to describe a linearly varying 
relationship between 𝑝𝐶𝑎50 and the myosin duty ratio (𝑟). We must first demonstrate the ability 
of myosin to activate the thin filament at subactivating calcium concentrations (figure 14). This 
shows that at a pCa of six (subactivating) a high myosin density can activate the thin filament 
which is seen in the increased sliding velocity as the concentration of myosin is increased. Thus 
myosin is capable of activating the thin filament in addition to calcium activation. This allows us 
to discuss cooperativity and duty ratio with the goal that changing these parameters can affect 
change in muscle contraction. Cooperativity 𝑛𝐻 varies with r (figure 5). We then establish a 
basis for the effect of 𝑘𝑎𝑡𝑡 on 𝑝𝐶𝑎50  as it can be changed by inhibitors of  𝑘𝑎𝑡𝑡 (figure 7) and can 
even recover calcium sensitivity lost by the addition of amrinone (figure 10). Taken together 
these results suggest that 𝑘𝑑𝑒𝑡 and 𝑘𝑎𝑡𝑡 can both affect the calcium sensitivity or 𝑝𝐶𝑎50  of thin 
filament activation. The number of myosin heads N, available to bind has also been shown to 
affect 𝑝𝐶𝑎50  (16). This attains physiological relevance in the peak function (figure 5) that is seen 
at low ∙ 𝑟 . This figure describes the effect a protein modification or modification that alters duty 
ratio and subsequently lowers the cooperative coefficient has on the amount of calcium 
transported into the cell to achieve contraction. Namely that such a change would require a 
greater amount of calcium to achieve muscle contraction which could in turn place a metabolic 
strain on the cell. However, it is important to note that calcium sensitivity cannot be indefinitely 
increased by addition of compounds such as sucrose. First of all myosin duty ratio cannot 
theoretically exceed one. Secondly at finite values of N curves begin to saturate. In addition there 
are only so many myosin binding sites on actin which would also limit the calcium sensitivity of 
the system as these sites become saturated or as myosin heads spend longer and longer times in a 




The SCoR model of activation attempts to describe the related effects of 𝑛𝐻 , 𝑘𝑎𝑡𝑡 , 𝑘𝑑𝑒𝑡, 𝑝𝐶𝑎50  
and N which no current model does (13). Simulations suggest there is a linear relationship 
between 𝑝𝐶𝑎50  and 𝑁 ∙ 𝑟 (13). We use this model to predict a relationship between 𝑁 ∙ 𝑟 and the 
cooperativity coefficient of myosin binding (figure 5). This suggests that maximum cooperativity 
is reached near physiological duty ratios (figure 4). Cooperativity is constrained by 𝑛𝑡  (figure 1 
and 2). This shows us that cooperative activation is not only calcium dependent but is also 
dependent on the concentration of myosin or duty ratio which is ≅
𝑛𝑏
𝑛𝑡
 where 𝑛𝑏 is the number of 
myosin heads bound divided by the total number of myosin heads available 𝑛𝑡. Not only is duty 
ratio affected by amrinone but so too is overall velocity, and thus activation of the thin filament 
(figure 3). This is likely due to the notion that amrinone is an inhibitor of ADP release and thus 
the rate of detachment. This means that each strongly bound myosin head would, in effect, 
remain bound longer with increasing concentration of amrinone. An increase in the number of 
strongly bound heads would slow the overall ATPase cycle slowing velocity. This increase in the 
number of strongly bound heads makes it more likely that at least one head remains bound at any 
one time allowing the next binding event to occur in an unregulated or calcium insensitive 
fashion. This is why we see a decrease in calcium sensitivity with increase in amrinone 
concentration (figure 9). Taken together figures 2, 4, 7, 9, and 10 confirm the hypothesis that 
ATPase kinetics tune calcium sensitivity and effect cooperativity of myosin binding (amrinone 
affects 𝑘𝑑𝑒𝑡) and (sucrose affects 𝑘𝑎𝑡𝑡).  
Cooperativity and calcium sensitivity become physiologically relevant in their ability to increase 
and decrease the amount of calcium the cell must move in and out to achieve muscle contraction. 
The more calcium one must move in and out to achieve contraction the greater the metabolic 




compounding problem in which cells must progressively move in and out greater and greater 
concentrations of calcium as loss of function occurs elsewhere in the muscular contraction 
system. To calculate the cooperative coefficients of myosin binding (figures 2 and 4) a 
cooperative relationship had to be assumed requiring our curve analysis to be a Hill fit. 
Additionally the relationship between velocity and activation or 𝑘𝑎𝑡𝑡 is likely more complicated 
than what we assume in saying that velocity is a direct measure of activation of the thin filament.  
There continues to be a debate over whether or not the weak binding state of actin-myosin is 
indeed on the pathway to the strongly bound state (15). We explore this in figures 11 and 15. 
Figure 11 shows the effect of phosphate on the velocity of the thin filament with varying myosin 
density against a control (which only varies myosin density). The addition of phosphate should 
push the equilibrium towards the actin, myosin, ADP, phosphate state. If the weakly bound state 
was able to transition immediately and quickly to the strongly bound state thus activating the thin 
filament we would expect to see an increase in the overall rate of the ATPase cycle. This would 
mean a faster velocity as we would be increasing the cycling of the myosin heads binding and 
unbinding on the actin filaments. As shown in figure 11 this is not quite the case. The control and 
phosphate curves initially start at the same velocities but quickly diverge with the phosphate 
velocity decreasing quickly as we raise the concentration of myosin. This seems to suggest that 
the weak binding state can saturate thus slowing velocity. This suggests that there are multiple 
weak binding transition states formed and that only from a select few can actin and myosin 
transition to a strongly bound productive state. Therefore with a load inducing concentration of 
myosin we see these weakly bound states formed and as they become saturated they alternate 
between each other at a rate of 𝑘9  and between weakly bound and dissociated at a rate of 𝑘5 or 




weak and dissociated, and weak and strong binding some of which would be more favorable than 
others. This would create a decrease in velocity at high myosin concentrations with phosphate 
addition due to a shift in equilibrium towards a weakly bound blue state (figure 15). An 
alternative hypothesis would be a transition from a dissociated to strongly bound state without 
the intermediate weak interactions. This pathway to strong binding is shown in red (figure 15). 
We further test these weak interactions with the use of pPDM modified myosin S-1. pPDM 
myosin is known to increase the number of weakly bound myosin heads meaning that to achieve 
contraction one would need to move more calcium into the cell overcoming the ionic drag 
created by such weak binding events. As shown in figure 12 we see an increase of 𝑝𝐶𝑎50 to 4.91. 
This is significantly more calcium than what is required in the control curve with 𝑝𝐶𝑎50 of 6.17. 
The drastic increase in calcium needed for half maximal activation suggests that the weak 
binding state is not holding tropomyosin off the actin binding sites or increasing the number of 
heads able to transition to the strongly bound state but rather that if found in a weakly bound 
state myosin heads are unable to progress to strongly bound easily. This much larger amount of 
calcium suggests the need for largely calcium dependent activation and not weak to strong 
transitioning. It should be noted here that more analysis is needed to make greater determinations 
on the nature of weak binding saturation and transition pathways. For instance although ionic 
strength can be accounted for with the addition of phosphate by changing concentration of KCl it 
should be noted that this is a difference in the type of ions that we did not control for. It could be 
that an addition of phosphate could interact with an amino acid residue inside the binding 
domain of the S-1 subfragment thereby inhibiting binding in a manner we did not discuss.  
Here we have discussed the ability of myosin to bind cooperatively to actin and shown that 




in myosin concentration or use of inhibitors like amrinone. In addition we have shown the 
effectiveness of the SCoR model of actomyosin binding kinetics and discussed the ways in 
which duty ratio and N bound can tune calcium sensitivity. Finally we have proposed an 
alternative to the transition between weakly and strongly bound through the use of pPDM and 
phosphate. The further study of these effects could lead to advancements in the treatment of 
cardiomyopathies, the macroscale modeling of muscle contraction, and loss of function mutation 
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